| Bioactivity | VEGFR-2-IN-13 (Compound 19a) is a potent VEGFR-2 inhibitor with an IC50 of 3.4 nM. VEGFR-2-IN-13 disrupts the HepG2 cell cycle by arresting the G2/M phase and induces apoptosis[1]. |
| Invitro | VEGFR-2-IN-13 (Compound 19a) shows anti-proliferative activities with IC50 values of 8.2 µM and 5.4 µM against MCF-7 and HepG2 cells, respectively[1]. |
| Name | VEGFR-2-IN-13 |
| Formula | C24H18N6O2S |
| Molar Mass | 454.50 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |